{"name":"Convergent Therapeutics","slug":"convergent-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxNZUF1QUp5V1BjT0I5LV9vUG9VS2paaUhrdUYtcVB0R29lWHlXbThUam5pVUgtcnJnZFdaSTRpTHNDWklLQ2ZPUGZqbUhQQUZaUEJkMEFIanlpN0t5SXdDX1ZHYnRYQ2FWUGJGZzdPRFRraEZHTlVRUDhFbHc3WnNuTEdqZ3ZhT3JtQ1NIbUFhOW1uM2tYMjRHX2VseEhUQnotTkVfcEtLRmVJVUVUSGtxdTl0a1pzNGxLMm9PdnhDN0J2ZS1GLVE?oc=5","date":"2026-03-20","type":"pipeline","source":"AD HOC NEWS","summary":"Y-mAbs Therapeutics stock: Former CEO joins radiopharma board amid biotech sector shifts - AD HOC NEWS","headline":"Y-mAbs Therapeutics stock: Former CEO joins radiopharma board amid biotech sector shifts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPRHdBdkotaE5HSDdXS29udGhKU0lxLU41bHhScXJVMVlETjl3aFhkNC1UQkl5V3dweWRGYkF0TjdxM2VIQUkyamUzSmZkODY1U0hDNHJTTGNIYTBQc2hVUWZmaGEyMU5LaDdNX1hkdHlxQ3hmeWVjdnVKX1J5Zi1Qa1FtcWR0TUw0dWNRZnFhZmZuSVFsUjFRd1p5OG1OYjVfZS1rUnBjU0xHbzlDT2ZjRkdrT2I5NDBmdFNzcU54WG9wR0FncDYwV3NlMS1sRWQ2LUtVdkpuYVMtRkQ4Rzl6a2NoTkNuMWhjVWNxQzM4VXc1d0l2LUcxT1JR?oc=5","date":"2026-03-19","type":"pipeline","source":"Business Wire","summary":"Convergent Therapeutics Appoints Radiopharmaceutical Industry Veteran Michael Rossi to its Board of Directors - Business Wire","headline":"Convergent Therapeutics Appoints Radiopharmaceutical Industry Veteran Michael Rossi to its Board of Directors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgJBVV95cUxQbEN5WWhIR0psYXlsLTJONFJPeVJia1Y4X1h1eVdrbUVpdkJxTHVDWlRHcjNFOTkwcklLcGo4ZjBRSHZZSG90Z3llRVdXdFJUeDltUkFqc1Q0Z25IYkdsQk9ESEZ3MFF4YnFkaWR2MF9ILVg2QXcwYkx5NDg5RGhHN0ZPaXA4QnFTZkpOb3VzTy1qSkVXRjc4ek1rQUdvOW9RQjZOSF9JWjdTeUJVM2l3clJvTGt4NmxZQjRrdnZzZ2dMUkREcndlMW5MVzBiSXdFQk9tNm1TQXRMd05VT0JBRE5NVFI0bm5aQkpzX3R5MXNTMW5hd0R3N3ZLa3oxOVBxZ2pLbHpaU1oxTExEaE1tSzlNRW53aEtwbXJ1QUVMMlBSUV9xanRGa1hZSG8yRkJnYWc?oc=5","date":"2026-03-12","type":"pipeline","source":"prnewswire.com","summary":"Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharmaceutical Innovation | DelveInsight - prnewswire.com","headline":"Radioligand Therapies Market Set for Significant Growth by 2034, Driven by Rising Cancer Burden and Targeted Radiopharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE04a1RKLVhMb21Ea0xvOGQ3NHVtSHc2azdFVmNyNlJpSE9wT3ZLaVNtRXcxMlNYeWhlYW96NnZ5ZVN1bml2NTluSWhyVnY2WWRTX3pzZXM0UGpjSkxS?oc=5","date":"2026-02-02","type":"trial","source":"EurekAlert!","summary":"Randomized trial finds drug therapy reduces hot flashes during prostate cancer treatment - EurekAlert!","headline":"Randomized trial finds drug therapy reduces hot flashes during prostate cancer treatment - EurekAlert!","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxQMFdTdlFLZ0JpVWFoVkh2RnBJaGxPRlNLRE1tbi12LTc2Nll2cldCS1JBSUlzOF9tNDRwRWpLNkh6RlNEZm9sZ21DUlBVSkNHeWg3aWt2RTFCYUlNS1lyUGl0NGRkWWJSQnZEZC1VQm5jZ2wwZ0V3endkeUdPY29FXy1NSUxDZjA3SVNGTHRTbDBwWVk?oc=5","date":"2025-10-21","type":"pipeline","source":"Yahoo Finance","summary":"Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence - Yahoo Finance","headline":"Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2025 American College of Rheumatology (ACR) Convergence","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPMHFlRkdpMmFnbWZFWkFSMkI0VTJLQzI1TEdQMThLS0ZNalg1ZWQ2SVI0cWRlVTRjbzFQSjNCMGtheWhoam9kNzQwa2lKRnpJUl9WWUJwMk8yRk9KNGQ0WUxmdzB6MUpqeTMxYzl2bno2UEFYeEg3aWszZGNkQ1loSm9TNkJSZjM5ZkFERFV6RVBaUk1BNHEwblY5QWVOY2E0RllHbWpHcUgxYmRHZmZzSGxoM1EtcG5QTGtNbNIBwgFBVV95cUxPMU9RZm5RdjlMSTZmU2xhakp2akxzTHRiT2xyZUpJVmd4eDM2NklDTm0tYmc4TVJCOXhXVDA2ZnVTQW5mWGtwWGhBdV82VVpwdndjWEVBTktqUmlMYXk1MWpxVFRUMXZpc0JiRC1tN3dxZ0htLTFERExJY1c0NTFRcW9fUGVXd2p6RktPNnJaY3gtNWYwa204cDktZlJQcnlnRndxWFgwXzM0TElTVjB0VWl2STBfeDRZdGw0eHFja0lKdw?oc=5","date":"2025-08-19","type":"pipeline","source":"Express Pharma","summary":"Reshaping healthcare: The convergence of digital therapeutics and point-of-care diagnostics - Express Pharma","headline":"Reshaping healthcare: The convergence of digital therapeutics and point-of-care diagnostics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6AFBVV95cUxOalU2LU5pYzRpT0lmMElPVzd5ZHJucHNKcFZtSnhWZjQ1OGtTMjRJUHRoQWRpMndnSTNSTWZCRF9oY1VtamhTeVF5d09Fekgxd2UtNzdma1djeGw5aXE1TFZVYXY1OHloakt4VlZrY3ZYbEU5TVJkaUdGaFJiNTZfRl9ZV3diWFpQZDVNbWhLTDIwSWkxdEpwb0pRVjJlYW1YU3pSTU9oR1Q0UklsbjduOFhibjhRY2YyQklNaWF2eTdOd3FhN2RLZi1CQlZWYncwZVg2VFpKbkJtMGNFM0hZTkh2LUc3ME14?oc=5","date":"2025-05-12","type":"pipeline","source":"News-Medical","summary":"PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics - News-Medical","headline":"PhoreMost makes key appointments to Board to advance development of next-generation degrader therapeutics - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE1lclp6c2ptcG52T2lVNlp0bkQzc2F6cmNILUFhY19lcTJMYy1FcGFrWi1vWGgwYU9yOU5vd1lCSDBoeFl6cFpWSUpYcFF3MmZlVU1V?oc=5","date":"2025-04-28","type":"pipeline","source":"FirstWord Pharma","summary":"Novo Holdings puts new investments on ice as economic storm clouds gather - FirstWord Pharma","headline":"Novo Holdings puts new investments on ice as economic storm clouds gather","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNSG1kSVJwT1NZRUp5VXR6RVk5UHh3eS1fOXl6d3Y1Tlk5Rm1uMkZ3QjRlYWxySGlDVTFlUmRQX0N6dW1XZ2ZRQzN1NEVvY2FtVmFzNHJJNjNBYkhfb29sNVB5YmFDaXlGRGI1NjF1RXBGdU5mRk9RNWF0UVdabmhld1BjdzN3RkRKc09tQTZHSHVoRGNNdWfSAZsBQVVfeXFMTnRXU002MmJsNzJybkZsdXJfOU9EZTU4OEZ2emUyT0hjR2lSdkg0Ql90ZDBleXNHSzlYclh2bkVwcnZXeS0zb2FXQWg2R215S0pGWlp0RUZDaGZ2SVhzMnhDajNlX09aZDcxTWNQWmI0VUk3OWdnaENTTlc0MmFmX2RuWThLZEcwdGMzZkZyeV9TSm4zXzNhaDhHNU0?oc=5","date":"2024-09-26","type":"pipeline","source":"Pulse 2.0","summary":"Convergent Therapeutics: $40 Million (Series A Extension) Secured From Novo - Pulse 2.0","headline":"Convergent Therapeutics: $40 Million (Series A Extension) Secured From Novo - Pulse 2.0","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPaTFNbTYxN2lLTzRXb2lyTXc2MzEtRWhjMlQwWTRjMWZocHB3OXQ3R2J2bHBwQTQtaU5BeUVKbW5tWW56WW5Gbm84dWF3ZFNKLTEwaWdseGFEU0hYYTZKclR3QzJMekFrd3JpQnZCOG93bUxrdGRpY0Iza0pPVDgtZy1iTk1nUG8?oc=5","date":"2024-08-14","type":"deal","source":"Pharmaceutical Technology","summary":"NorthStar and Convergent expand deal for prostate cancer drug - Pharmaceutical Technology","headline":"NorthStar and Convergent expand deal for prostate cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOOHpySU1yeW1YQzRDNDF3LVdvVEJsbDRHZVBHenpCakQ2LVRLaVA0SnFGWmpWdThiZWJrNHNEQjRuM1VWREJ1X3dLODFyYkVQTWViOW11WFEyTE44SWlZcDA0YjBKczZKZXdGRXVBdnpVT1lnUVBCbTN6SE05elljU3ZxQnhVT2ZseFhyRWQxR1VrT21LOFg3YmxYbjNkQQ?oc=5","date":"2023-05-05","type":"pipeline","source":"BioPharma Dive","summary":"Convergent raises $90M to develop its radiopharmaceutical for prostate cancer - BioPharma Dive","headline":"Convergent raises $90M to develop its radiopharmaceutical for prostate cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPMnd5aFRPdVp5WERmZHp3dVlRV1pNT3RCbU1jbVVvTW1hRXpIekllSGNYV3hTZm9hV2NXVGtGSFJHVERfWVdWTHpKclg4a2doMWtDNExIdGhTcmQyazdmM2NxTDdyLVktUXdHTVNpTFlvTHNrMmxMNFg3LV9YNUV1UC1rTVp5RVdacEp2emExa09ySjJOc0N4Y2FsUGs4Sk1C?oc=5","date":"2023-05-03","type":"pipeline","source":"Fierce Biotech","summary":"Radiopharmaceutical company Convergent closes series A to the tune of $90M - Fierce Biotech","headline":"Radiopharmaceutical company Convergent closes series A to the tune of $90M","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}